Gala Pharmaceutical Inc. Deferred Compensation Equity
Gala Pharmaceutical Inc. had Deferred Compensation Equity of $31.95 thousand as of 2019-05-31, per its 10-Q filed 2019-07-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2019-07-23
- 2019-05-31: Deferred Compensation Equity $31.95K.
- 2019-02-28: Deferred Compensation Equity $74.49K.
- 2018-11-30: Deferred Compensation Equity $117.02K.
- 2018-08-31: Deferred Compensation Equity $125.00K.
| Period end | Deferred Compensation Equity |
|---|---|
| 2019-05-31 | $31.95K 10-Q · filed 2019-07-23 |
| 2019-02-28 | $74.49K 10-Q · filed 2019-04-30 |
| 2018-11-30 | $117.02K 10-Q · filed 2019-07-23 |
| 2018-08-31 | $125.00K 10-Q · filed 2018-10-26 |
| 2018-05-31 | $51.09K 10-Q · filed 2018-08-01 |
| 2018-02-28 | $45.03K 10-Q · filed 2018-05-08 |
| 2017-11-30 | $165.85K 10-K · filed 2019-04-15 |
| 2017-08-31 | $309.22K 10-Q · filed 2017-10-19 |
| 2017-05-31 | $409.37K 10-Q · filed 2017-07-28 |
| 2016-11-30 | $0.00 10-K · filed 2018-04-06 |